GI Dynamics, Inc. develops therapies for obesity and diabetes. The Company also develops products for the treatment of obesity and its complications through novel removable devices that modify metabolic pathways. It develops devices that are delivered into the gastrointestinal tract using minimally invasive techniques. Its product include EndoBarrier Technology, delivers medical interventions for people combating weight problems and diabetes or diabetes risk factors. Data from clinical trials demonstrate that the EndoBarrier Gastrointestinal Liner provides glycemic control and significant weight loss by modifying metabolic pathways.